vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Creative Media & Community Trust Corp (CMCT). Click either name above to swap in a different company.
Creative Media & Community Trust Corp is the larger business by last-quarter revenue ($28.5M vs $21.2M, roughly 1.3× Autolus Therapeutics plc). Creative Media & Community Trust Corp runs the higher net margin — -125.8% vs -373.3%, a 247.5% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.
AUTL vs CMCT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $28.5M |
| Net Profit | $-79.1M | $-11.4M |
| Gross Margin | — | — |
| Operating Margin | -337.9% | -125.6% |
| Net Margin | -373.3% | -125.8% |
| Revenue YoY | — | 3.6% |
| Net Profit YoY | 3.6% | -11.4% |
| EPS (diluted) | $-0.30 | $-3.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $28.5M | ||
| Q3 25 | $21.2M | $26.2M | ||
| Q2 25 | $20.9M | $29.7M | ||
| Q1 25 | $9.0M | $32.3M | ||
| Q4 24 | — | $27.5M | ||
| Q3 24 | $0 | $28.6M | ||
| Q2 24 | $0 | $34.4M | ||
| Q1 24 | $10.1M | $34.0M |
| Q4 25 | — | $-11.4M | ||
| Q3 25 | $-79.1M | $-12.5M | ||
| Q2 25 | $-47.9M | $-9.0M | ||
| Q1 25 | $-70.2M | $-6.1M | ||
| Q4 24 | — | $-10.3M | ||
| Q3 24 | $-82.1M | $-10.4M | ||
| Q2 24 | $-58.3M | $-796.0K | ||
| Q1 24 | $-52.7M | $-3.7M |
| Q4 25 | — | -125.6% | ||
| Q3 25 | -337.9% | -47.7% | ||
| Q2 25 | -292.6% | -30.3% | ||
| Q1 25 | -726.3% | -19.0% | ||
| Q4 24 | — | -128.8% | ||
| Q3 24 | — | -36.9% | ||
| Q2 24 | — | -1.6% | ||
| Q1 24 | -384.1% | -10.7% |
| Q4 25 | — | -125.8% | ||
| Q3 25 | -373.3% | -47.5% | ||
| Q2 25 | -229.0% | -30.3% | ||
| Q1 25 | -781.1% | -18.9% | ||
| Q4 24 | — | -129.8% | ||
| Q3 24 | — | -36.3% | ||
| Q2 24 | — | -2.3% | ||
| Q1 24 | -522.1% | -11.0% |
| Q4 25 | — | $-3.89 | ||
| Q3 25 | $-0.30 | $-23.52 | ||
| Q2 25 | $-0.18 | $-18.94 | ||
| Q1 25 | $-0.26 | $-20.73 | ||
| Q4 24 | — | $97.71 | ||
| Q3 24 | $-0.31 | $-305.04 | ||
| Q2 24 | $-0.22 | $-98.64 | ||
| Q1 24 | $-0.24 | $-125.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $15.4M |
| Total DebtLower is stronger | — | $509.8M |
| Stockholders' EquityBook value | $265.5M | $265.4M |
| Total Assets | $661.9M | $859.2M |
| Debt / EquityLower = less leverage | — | 1.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $15.4M | ||
| Q3 25 | $86.1M | $17.3M | ||
| Q2 25 | $123.8M | $27.8M | ||
| Q1 25 | $95.8M | $19.8M | ||
| Q4 24 | — | $20.3M | ||
| Q3 24 | $657.1M | $18.5M | ||
| Q2 24 | $705.9M | $29.3M | ||
| Q1 24 | $758.5M | $21.3M |
| Q4 25 | — | $509.8M | ||
| Q3 25 | — | $527.8M | ||
| Q2 25 | — | $535.6M | ||
| Q1 25 | — | $512.7M | ||
| Q4 24 | — | $505.7M | ||
| Q3 24 | — | $478.3M | ||
| Q2 24 | — | $485.1M | ||
| Q1 24 | — | $472.8M |
| Q4 25 | — | $265.4M | ||
| Q3 25 | $265.5M | $281.9M | ||
| Q2 25 | $346.5M | $287.1M | ||
| Q1 25 | $371.1M | $293.0M | ||
| Q4 24 | — | $304.5M | ||
| Q3 24 | $477.0M | $321.0M | ||
| Q2 24 | $527.8M | $351.1M | ||
| Q1 24 | $582.0M | $369.9M |
| Q4 25 | — | $859.2M | ||
| Q3 25 | $661.9M | $871.8M | ||
| Q2 25 | $721.0M | $885.0M | ||
| Q1 25 | $746.3M | $882.3M | ||
| Q4 24 | — | $889.6M | ||
| Q3 24 | $827.5M | $868.0M | ||
| Q2 24 | $853.6M | $891.2M | ||
| Q1 24 | $901.4M | $887.5M |
| Q4 25 | — | 1.92× | ||
| Q3 25 | — | 1.87× | ||
| Q2 25 | — | 1.87× | ||
| Q1 25 | — | 1.75× | ||
| Q4 24 | — | 1.66× | ||
| Q3 24 | — | 1.49× | ||
| Q2 24 | — | 1.38× | ||
| Q1 24 | — | 1.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $5.8M |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.8M | ||
| Q3 25 | $-67.9M | $3.7M | ||
| Q2 25 | $-72.8M | $-2.5M | ||
| Q1 25 | $-75.6M | $1.2M | ||
| Q4 24 | — | $17.0M | ||
| Q3 24 | $-76.7M | $10.3M | ||
| Q2 24 | $-51.1M | $3.9M | ||
| Q1 24 | $-40.5M | $1.6M |
| Q4 25 | — | — | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | — | ||
| Q1 25 | $-83.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | — | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | — | ||
| Q1 25 | -933.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 34.8% | — | ||
| Q1 25 | 91.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
